Exactech Inc (EXAC)

26.88
NASDAQ : Health Care
Prev Close 26.88
Day Low/High 0.00 / 0.00
52 Wk Low/High 16.11 / 27.98
Avg Volume 58.80K
Exchange NASDAQ
Shares Outstanding 14.10M
Market Cap 379.48M
EPS 1.10
P/E Ratio 25.40
Div & Yield N.A. (N.A)

Latest News

Exactech Expands Competency In 3-D Printing With Purchase Of Arcam Q10plus Systems

Exactech Expands Competency In 3-D Printing With Purchase Of Arcam Q10plus Systems

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, has confirmed the purchase of two Arcam Q10plus machines this...

A Drawing Depicts Plans To Recognize The Newly Named Exactech Arena At The Stephen C. O'Connell Center, A Sports And Entertainment Complex At The University Of Florida In Gainesville, Fl. The Remodeled Facility Is Scheduled To Re-open In December 2016. (Photo: Business Wire)

A Drawing Depicts Plans To Recognize The Newly Named Exactech Arena At The Stephen C. O'Connell Center, A Sports And Entertainment Complex At The University Of Florida In Gainesville, Fl. The Remodeled Facility Is Scheduled To Re-open In December 2016. (Photo: Business Wire)

Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, announced today an expansion of its long-standing partnership with the...

Exactech Commemorates 20 Years On Nasdaq With A Proven Record Of Growth. Exactech Is A Developer And Producer Of Bone And Joint Restoration Products And Biologic Materials For Extremities, Knee, Hip And Spine. (Nasdaq: EXAC)(Graphic: Business Wire)

Exactech Commemorates 20 Years On Nasdaq With A Proven Record Of Growth. Exactech Is A Developer And Producer Of Bone And Joint Restoration Products And Biologic Materials For Extremities, Knee, Hip And Spine. (Nasdaq: EXAC)(Graphic: Business Wire)

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, announced today that in honor of the company's 20th...

Exactech Q1 Revenue Up 6% To $65.3 Million

Exactech Q1 Revenue Up 6% To $65.3 Million

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced revenue of $65.

Exactech Receives FDA 510(k) Clearance For Vantage™ Total Ankle

Exactech Receives FDA 510(k) Clearance For Vantage™ Total Ankle

Exactech Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologic materials, announced today it has received clearance from the U.

Exactech Schedules First Quarter 2016 Earnings Release And Conference Call

Exactech Schedules First Quarter 2016 Earnings Release And Conference Call

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, will release its first quarter financial results after the market closes...

Insider Trading Alert - AGNC, EXAC And TRC Traded By Insiders

Insider Trading Alert - AGNC, EXAC And TRC Traded By Insiders

Stocks with insider trader activity include AGNC, EXAC and TRC

Exactech Announces Completion Of Corporate Integrity Agreement Requirements

Exactech Announces Completion Of Corporate Integrity Agreement Requirements

Exactech Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologic materials, announced today that it has completed the requirements of its five-year...

Exactech Innovations Presented At 2016 Orthopaedic Research Society Annual Meeting

Exactech Innovations Presented At 2016 Orthopaedic Research Society Annual Meeting

Exactech Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologic materials, will present more than 25 scientific posters and presentations regarding...

Exactech Innovations Simplify The Complexity Of Revision Total Joint Replacement

Exactech Innovations Simplify The Complexity Of Revision Total Joint Replacement

Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologic solutions, announced today its lineup of products to be unveiled at the company's...

Exactech 2015 Revenue $241.8 Million, Net Income $14.8 Million, EPS $1.04

Exactech 2015 Revenue $241.8 Million, Net Income $14.8 Million, EPS $1.04

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, announced today that revenue for 2015 decreased 3% to $241.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BGG, DLB, EXAC, POPE, VTR, WERN Downgrades: ARKR, CAMT, CETX, CYH, ELNK, FET, NYRT, ULBI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Exactech Schedules Fourth Quarter And Year End 2015 Earnings Release And Conference Call

Exactech Schedules Fourth Quarter And Year End 2015 Earnings Release And Conference Call

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, will release its fourth quarter and year end 2015 financial results...

Exactech Acquires Australian Distributor

Exactech Acquires Australian Distributor

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, announced today the acquisition of its independent distribution partner,...

Exactech Announces The Sale Of Its Dental Biologic Assets To Salvin Dental Specialties

Exactech Announces The Sale Of Its Dental Biologic Assets To Salvin Dental Specialties

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today the sale of substantially all of the assets of its dental biologics business...

Exactech Announces Renewal Of $150 Million Senior Secured Debt Credit Facility

Exactech Announces Renewal Of $150 Million Senior Secured Debt Credit Facility

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today the five year renewal and increase of its Senior Secured Revolving Credit...

Exactech Announces Stock Repurchase Authorization

Exactech Announces Stock Repurchase Authorization

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today that its board of directors has authorized the company to buy back up to 1.

Bearish Bets: Small-Cap Energy Names Like Range Resources Get Crushed

RRC, EXAC, ALXN, AMAG and DK were all recently downgraded by TheStreet’s Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AOSL, BKU, CFNB, CSS, CUI, ESRT, GTY, REXR, RNET, TNAV Downgrades: ABC, ALLE, ALXN, CVI, EXAC, HT, JAH, MDP, MYE, OSK, ROG, UHT, WHF Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Exactech Q3 2015 Revenue $56.2 Million. Net Income $2.9 Million. Diluted EPS $0.20.

Exactech Q3 2015 Revenue $56.2 Million. Net Income $2.9 Million. Diluted EPS $0.20.

Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today revenue of $56.

Exactech Innovations Presented At Key Scientific Conference

Exactech Innovations Presented At Key Scientific Conference

Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, today recounted 18 studies presented at key scientific conferences this Fall, including an...

Exactech Announces Third Quarter 2015 Earnings Release Date And Updates Third Quarter Estimates

Exactech Announces Third Quarter 2015 Earnings Release Date And Updates Third Quarter Estimates

Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, said today the company's financial results for the third quarter...

Exactech Broadens Spine Portfolio With Launch Of Anchored Anterior Cervical Interbody Device At NASS 2015

Exactech Broadens Spine Portfolio With Launch Of Anchored Anterior Cervical Interbody Device At NASS 2015

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today the launch of the new Acapella ® One Cervical Spacer System with...

Exactech Announces Successful First Surgery With New Equinoxe® Shoulder Reconstruction Prosthesis

Exactech Announces Successful First Surgery With New Equinoxe® Shoulder Reconstruction Prosthesis

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today the successful first surgery using its new Equinoxe ® Humeral...

Exactech Announces Successful First Surgeries With New Alteon® Monobloc Revision Hip Stem

Exactech Announces Successful First Surgeries With New Alteon® Monobloc Revision Hip Stem

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today successful first surgeries using its new Alteon ® Monobloc Revision...

Exactech Announces Successful First Surgeries With New Revision Knee System

Exactech Announces Successful First Surgeries With New Revision Knee System

Exactech, Inc. (Nasdaq: EXAC), a worldwide developer and producer of bone and joint restoration products, announced today the successful first surgeries performed with its new revision knee system.

ExactechGPS® Guided Personalized Surgery Is A Powerful, Yet Compact Advanced Surgical Technology Platform That Delivers Efficiency And Reproducibility In Total Joint Replacement. (Photo: Business Wire)

ExactechGPS® Guided Personalized Surgery Is A Powerful, Yet Compact Advanced Surgical Technology Platform That Delivers Efficiency And Reproducibility In Total Joint Replacement. (Photo: Business Wire)

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, reported today that surgeons around the world are expressing positive response to Exactech's...

Exactech Masters Course Sets Standard In Specialized Medical Education

Exactech Masters Course Sets Standard In Specialized Medical Education

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, hosted more than 70 shoulder specialists at its recent Shoulder Masters Course in San...